Terns Pharmaceuticals jobs

Lucia CoPilot- Contract work in the Travel Industry United States | [Remote] | Remote

CDD - Maquilleur / vendeur - Bobbi Brown - Ternes 35h H/F/X Paris,FR-75,France

Pharmaceutical Sciences, Technology & Innovation Lead (Sr. Director) Boston, MA posted: Posted Yesterday

Pharmaceutical Technician II Singapore, Singapore Embrace the role of a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and support quality manufacturing processes. If you have hands-on experience in pharmaceutical manufacturing and a passion for safety and precision, this is your opportunity to make an impact.

Pharmaceutical Technician II Singapore, Singapore Embrace the role of a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and support quality manufacturing processes. Ideal for candidates with 1-5 years' experience in pharma, this role offers hands-on work in a dynamic, safety-focused environment. Grow your career in pharmaceutical manufacturing today!

Pharmaceutical Technician II Singapore, Singapore Embrace the role of a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and contribute to quality manufacturing. If you have hands-on experience in pharma production and a passion for safety and precision, this is your opportunity to make a difference.

Pharmaceutical Sciences, Operations & Performance Lead (Sr. Director) Boston, MA posted: Posted 30+ Days Ago

Pharmaceutical Technician II Singapore, Singapore Embrace the opportunity to become a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and contribute to quality manufacturing. If you have hands-on experience in pharma production and a passion for safety and precision, this is your opportunity to make a difference.

Senior Pharmaceutical Sales Specialist, Specialty Care CVRM - Annapolis, MD US - Annapolis - MD posted: Posted 21 Days Ago

Senior Scientist, Analytical Sciences South San Francisco, CA, United States Company Description: ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients' lives by Overcoming Resistance In Cancer. ORIC's clinical stage product candidates include (1) rinzimetostat (ORIC-944), an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and (2) enozertinib, a brain penetrant inhibitor that selectively targets EGFR exon 20, HER2 exon 20 and EGFR atypical mutations, being developed across multiple genetically defined cancers. Beyond these two product candidates, ORIC® is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC has offices in South San Francisco and San Diego, California. For more information, please go to www.oricpharma.com , and follow us on X or LinkedIn . We are seeking a lab-based, highly motivated Senior Scientist in Analytical Sciences. The candidate will be part of cross-functional teams providing analytical leadership on projects, work closely on a shared mission to bring new therapeutics to cancer patients. The successful candidate will report to the Sr. Director of Analytical Sciences Job Description: Independently lead analytical development and product characterization activities for our drug development portfolios. Provide oversight, technical guidance and tactical direction for analytical method development, transfer, validation, release, and stability testing activities at CDMOs. Function as a subject matter expert for in-depth physical/ chemical characterization of NCEs at CROs. Independently conceptualize, design, and conduct experiments; interpret and present data and conclusions to various audience, including senior leadership. Expected to

Principal or Associate Scientist, Analytical Development Japan (Late Stage), Pharmaceutical Sciences Fujisawa, Japan posted: Posted Today

Principal or Associate Scientist, Analytical Development Japan, Pharmaceutical Sciences Fujisawa, Japan posted: Posted 30+ Days Ago

Lead Director, Pharmaceutical Contracting Work at Home, Illinois, United States Join us as Lead Director, Pharmaceutical Contracting and drive high-impact negotiations with major pharmaceutical manufacturers. Shape strategy, foster partnerships, and lead rebate initiatives in a dynamic healthcare environment. If you excel in complex contract negotiations and thrive in leadership roles, this is your opportunity to make a significant impact.

Specialist, BTS CHN - Zhejiang - Ningbo posted: Posted 18 Days Ago

Associate Director or Principal Scientist, Facility Operations, Pharmaceutical Sciences Fujisawa, Japan posted: Posted 30+ Days Ago

Pharmaceutical Sales Specialist Immunology - Alsace Remote - France posted: Posted 4 Days Ago

Clinical Sales Specialist (CS) - Jacksonville South Jacksonville, Florida, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The CS is accountable for implementing the sales strategies for approved products consistent with Corcept's compliance standards as well as all applicable legal requirements for those key targeted health care providers and hospital systems within an assigned territory. Responsibilities: - Build and develop professional relationships with influential high prescribers and thought leaders in the territory to enhance Corcept brand and product loyalty - Leverages expertise and knowledge of the therapeutic disease state, the marketplace, applicable competitors, industry, and cross-functional activities/plans to anticipate and effectively manage business opportunities and challenges - Develops and implements effective customer specific territory plans and communicates insights to internal stakeholders - Prioritizes time and effort to ensure optimal coverage of appropriate physician specialists based on opportunity and potential - Plan and participate in education programs and speaker dinner programs - Manage territory

Senior Vice President, Sales Flexible/ U.S. Based Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the communities we serve. We are a clinical-stage company currently focused on post-bariatric hypoglycemia (PBH), Wolfram syndrome, and amyotrophic lateral sclerosis (ALS). Our mission is powered by our people. Our core values - be audacious, be curious, be authentic, be engaged, and be accountable - creating a culture of caring. Amylyx has assembled an experienced team ready to take action because the communities we serve have no time to wait. If you share our passion and are determined to tackle some of medicine's toughest problems, we encourage you to read the opportunity below and apply. The Opportunity The SVP of Sales will play a critical leadership role in building and executing the commercial strategy for a pre‑commercial biotechnology company preparing for its first product launch. This individual will be responsible for designing and implementing the Go‑To‑Market (GTM) strategy, recruiting and developing a high‑performing sales organization, establishing strong relationships with Key Opinion Leaders (KOLs), ensuring full sales force readiness ahead of launch and driving performance. We anticipate hiring the Senior Vice President, Sales in September 2026. The ideal candidate combines strategic vision with hands‑on execution experience in specialty pharma or biotech launches and thrives in a fast‑paced, build‑from‑scratch environment. Responsibilities Enterprise Commercial Leadership - Shape overall U.S. commercial

Technician, Pharmaceutical Sligo, SO, Ireland Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: We are recruiting a Pharmaceutical Technician to join our team on site in Manorhamilton Road, Sligo on a 12 month fixed-term contract. This role is rotational shift work. In your role as Pharmaceutical Technician you will be responsible for producing drug product materials as per organizational needs in line with all relevant compliance requirements. This person will operate as a team member in a pharmaceutical processing facility in line with all regulatory and organizational requirements. A snapshot of your key responsibilities as a Pharmaceutical Technician would be: Pharmaceutical processing activities in our manufacturing building and support locations. Team co-ordination to maximise the effectiveness of the team members. Documentation of all activities in line with cGMP requirements. Cross training within the team and training of new team members. Participation in continuous improvement programs to implement improvements in the quality, safety, environmental and production systems. Execution of commissioning and validation protocols on an ongoing basis. Maintaining the overall cGMP of the pharmaceutical processing areas. Adheres

Medical Advisor - V&I - HN Vietnam - Hanoi posted: Posted 8 Days Ago

Diagnostics Partner - HN Vietnam - Hanoi posted: Posted 30+ Days Ago

Field Product Specialist _ Cardiovascular and Metabolism _ HN Vietnam posted: Posted 10 Days Ago

Senior Specialist, Technology Partnership SGP - Singapore - Singapore (50 Tuas West Dr) posted: Posted 30+ Days Ago

Senior Medical Director Clinical Development Neuroscience Remote, Hybrid, New Haven - CT Arvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. Arvinas uses its proprietary PROTAC® Discovery Engine platform to engineer proteolysis targeting chimeras, or PROTAC® targeted protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Arvinas is currently progressing multiple investigational drugs through clinical development programs, including ARV-102, targeting LRRK2 for neurodegenerative diseases; ARV-806, targeting KRAS G12D for mutated cancers, including pancreatic, colorectal, and non-small cell lung cancers; ARV-393, targeting BCL6 for relapsed/refractory non-Hodgkin Lymphoma; ARV-027, targeting the polyglutamine-expanded androgen receptor, or polyQ-AR, in skeletal muscle; and vepdegestrant, targeting the estrogen receptor for patients with locally advanced or metastatic ER+/HER2- breast cancer. On August 8 th 2025, the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for vepdegestrant- an investigational, orally bioavailable PROTAC estrogen receptor degrader- for its use as a monotherapy in the treatment of adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-), ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based therapy. In September 2025, Arvinas and Pfizer announced their plan to jointly select a third party for the out-licensing and commercialization of vepdegestrant. In April 2024, Arvinas entered into a transaction with Novartis, including a global license agreement for the development